| Retrospective Study of Brachytherapy (NCT05242861) | Zhejiang Cancer Hospital | 2022-02-20 |
| Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms (NCT06774482) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-05-19 |
| Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations (NCT04579380) | Seagen, a wholly owned subsidiary of Pfizer | 2021-01-11 |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial (NCT04679675) | Kaiser Permanente | 2020-11-20 |
| Impact of the COVID-19 Pandemic in Gynecological Oncology (NCT04351139) | Hospices Civils de Lyon | 2020-05-06 |
| An In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure (NCT03971032) | Hillel Yaffe Medical Center | 2019-12-31 |
| Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer. (NCT04061967) | Karolinska Institutet | 2019-08-19 |
| Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer (NCT03951415) | Leiden University Medical Center | 2019-07-08 |
| Sentinel Node Mapping in Women With Endometrial and Cervical Cancer (NCT02820506) | University of Southern Denmark | 2017-02-27 |
| Sentinel Node Mapping in Women With Cervical and Endometrial Cancer (NCT02825355) | University of Southern Denmark | 2017-02-27 |
| MRI and Metabolomics Biomarkers for Uterine Malignancy (NCT02528864) | Chang Gung Memorial Hospital | 2015-08-01 |
| Biobehavioral Intervention in Gynecologic Oncology Patients (NCT02454036) | Rachel Miller | 2015-06-01 |
| Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients (NCT02374411) | Edward Hospital | 2014-09-01 |
| RT for Cervical Adenocarcinoma/adenosquamous Carcinoma (NCT06741046) | Peking Union Medical College Hospital | 2014-06-01 |
| Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology (NCT01969396) | Cook Group Incorporated | 2013-10-01 |
| Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation (NCT01998854) | Gynesonics | 2013-02-01 |
| Sentinel Node Biopsy in Endometrial Cancer (NCT01564264) | Hamilton Health Sciences Corporation | 2012-11-01 |
| A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer (NCT01654458) | Women's College Hospital | 2012-07-01 |
| Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms (NCT03624712) | University Hospital Tuebingen | 2012-01-01 |
| ChemoFx® PRO - A Post-Market Data Collection Study (NCT00669422) | Precision Therapeutics | 2006-10-01 |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer (NCT00377520) | Eli Lilly and Company | 2006-09-01 |
| Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent (NCT00361036) | Worthington-Kirsch, Robert L., M.D. | 2006-08-01 |
| A Trial for Patients With Gestational Trophoblastic Disease (NCT00190918) | Eli Lilly and Company | 2006-07-01 |
| A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) (NCT00628901) | Boston Scientific Corporation | 2006-01-01 |
| A Trial for Patients With Advanced/Recurrent Cervical Cancer (NCT00190983) | Eli Lilly and Company | 2005-02-01 |
| Acupuncture for Women's Health Conditions (NCT00090389) | National Center for Complementary and Integrative Health (NCCIH) | 2005-01-01 |
| Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers (NCT00231855) | Montefiore Medical Center | 2004-11-01 |
| Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide (NCT00188695) | University Health Network, Toronto | 2004-04-01 |
| Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) (NCT00188578) | University Health Network, Toronto | 2003-06-01 |
| Magnetic Resonance Imaging Guided Gynecologic Brachytherapy (NCT00112307) | Brigham and Women's Hospital | 2003-03-01 |
| Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer (NCT00782041) | Sanofi | 2003-01-01 |
| Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma (NCT00050440) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-07-01 |
| Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids (NCT00100191) | ZonMw: The Netherlands Organisation for Health Research and Development | 2002-02-01 |
| Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy (NCT00505492) | M.D. Anderson Cancer Center | 2002-02-01 |
| Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis (NCT00250770) | University of New Mexico | 1998-01-01 |